Websites, domains, hosts that links to pharma.us.novartis.com
Our database shows, that the website pharma.us.novartis.com is linked by a total of 31 websites.
Number of websites/domains displayed: 31
Results found: 31
Websites discovered:
Novartis – Patient Assistance NOW - Homehttp://pageoverview.com/website-report/patientassistancenow.com
- Expected expiration: November 27th in 2017
- Creation date: November 27th in 2007
- Renew date: October 26th in 2015
- Google Analytics: 4621572-1
Learn about ITP (immune thrombocytopenia) | MyITPLifehttp://pageoverview.com/website-report/myitplife.com
Discover more about acute and chronic ITP, as well as its symptoms and treatments. Understand how an ITP diagnosis can have an impact on your daily life.
- Expected expiration: December 2nd in 2018
- Creation date: December 2nd in 2015
- Renew date: April 13th in 2016
ILARIS® (canakinumab)http://pageoverview.com/website-report/ilaris.com
- Expected expiration: December 8th in 2019
- Creation date: December 8th in 1999
- Renew date: November 6th in 2017
Pill for Relapsing MS | RRMS Treatment | GILENYA (fingolimod)http://pageoverview.com/website-report/gilenya.com
GILENYA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS) in adults. This once-a-day pill helps cut MS relapses in half.
- Expected expiration: May 28th in 2018
- Creation date: May 28th in 2010
- Renew date: April 26th in 2016
Multiple Sclerosis Treatment | EXTAVIAhttp://pageoverview.com/website-report/extaviahcp.com
EXTAVIA is a disease-modifying therapy (DMT) for people with relapsing forms of multiple sclerosis (MS). Learn about multiple sclerosis treatment and therapy.
- Expected expiration: May 18th in 2019
- Creation date: May 18th in 2015
- Renew date: April 17th in 2017
Eye Itch Relief | ZADITOR® Eye Dropshttp://pageoverview.com/website-report/zaditor.com
Learn more about ZADITOR® Eye Drops for 12-hour eye itch relief and get exclusive savings this season at Zaditor.com.
- Expected expiration: September 13th in 2017
- Creation date: September 13th in 2001
- Renew date: January 27th in 2017
MS Views & Newshttp://pageoverview.com/website-report/msviews.org
MS Views and News provides educational Multiple Sclerosis (MS) information via the internet (using our website, blog, e-Newsletter, YouTube Channel & Blog talk radio) and via live educational seminars.
- Expected expiration: May 26th in 2018
- Creation date: May 26th in 2010
- Renew date: May 11th in 2017
Alcon Glaucoma Support | MyGlaucomaSupport.comhttp://pageoverview.com/website-report/myglaucomasupport.com
The home of Alcon glaucoma support, helping you to understand glaucoma and intraocular pressure and learn about treatment options.
- Expected expiration: March 29th in 2019
- Creation date: March 29th in 2013
- Renew date: February 25th in 2017
- Google Analytics: 33423768-22
KYMRIAH™ (tisagenlecleucel) | Now FDA Approvedhttp://pageoverview.com/website-report/kymriah.com
KYMRIAH™ is a treatment option for pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia. See full Prescribing & Safety Info, including Boxed Warning.
- Expected expiration: February 27th in 2020
- Creation date: February 27th in 2014
- Renew date: January 26th in 2018
Home Pagehttp://pageoverview.com/website-report/focalinxr.com
- Expected expiration: January 19th in 2020
- Creation date: January 19th in 2005
- Renew date: December 18th in 2017
Acromegaly Info | What is Acromegaly?http://pageoverview.com/website-report/aboutacromegaly.com
- Expected expiration: September 26th in 2019
- Creation date: September 26th in 2011
- Renew date: August 25th in 2017
- Google Analytics: 2875276-2
COSENTYX (secukinumab)http://pageoverview.com/website-report/cosentyx.com
- Expected expiration: November 6th in 2018
- Creation date: November 6th in 2012
- Renew date: October 5th in 2016
Relapsing-remitting MS Treatment – Gilenya (fingolimod)http://pageoverview.com/website-report/gilenyahcp.com
Learn more about Gilenya, a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing-remitting MS. See ISI for details.
- Expected expiration: May 18th in 2019
- Creation date: May 18th in 2015
- Renew date: April 17th in 2017
A Guide to Living with Carcinoid Syndrome, Cancer, and Tumorshttp://pageoverview.com/website-report/carcinoid.com
Find information and resources for living with carcinoid syndrome, cancers, and tumors, including nutritional guides, symptom information, and more.
- Expected expiration: January 8th in 2018
- Creation date: January 8th in 1999
- Renew date: December 7th in 2015
- Google Analytics: 2875276-4
AFINITOR® (everolimus) | Official Site from Novartishttp://pageoverview.com/website-report/afinitor.com
The official website for AFINITOR® (everolimus) tablets. Find information about AFINITOR®, the conditions it treats, and Important Safety Information.
- Expected expiration: October 31st in 2017
- Creation date: October 31st in 2005
- Renew date: September 29th in 2015
HCP First by Novartis Pharmaceuticals Corporationhttp://pageoverview.com/website-report/hcpfirst.com
Welcome to HCP First, a resource from Novartis that allows HCPs to learn about medications, find office & patient support, and gain access to professional materials.
- Expected expiration: June 20th in 2019
- Creation date: June 20th in 2015
- Renew date: May 20th in 2017
REMS Safety Informationhttp://pageoverview.com/website-report/kymriah-rems.com
- Expected expiration: July 7th in 2021
- Creation date: July 7th in 2016
- Renew date: August 29th in 2017
Understanding Gastrointestinal Symptoms and Carcinoid Syndromehttp://pageoverview.com/website-report/whatamiwrestlingwith.com
Discover how carcinoid syndrome symptoms can be misdiagnosed as a gastrointestinal problem like IBS or gastritis, and learn when you should be tested.
- Expected expiration: June 9th in 2019
- Creation date: June 9th in 2017
- Renew date: June 9th in 2017
ノバルティスhttp://pageoverview.com/website-report/novartis.co.jp
- Creation date: August 26th in 1997
- Renew date: August 27th in 1997
IL-17A Antagonist for PsO, PsA, & AS - COSENTYX (secukinumab)http://pageoverview.com/website-report/cosentyxhcp.com
Learn about COSENTYX (secukinumab), the first fully human IL-17A antagonist approved for plaque psoriasis, psoriatic arthritis, andankylosing spondylitis.
- Expected expiration: May 18th in 2019
- Creation date: May 18th in 2015
- Renew date: April 17th in 2017
Science of Migraine | For Health Care Professionalshttp://pageoverview.com/website-report/scienceofmigraine.com
Find migraine disease data and information on migraine pathophysiology, as well as an understanding of current migraine management, here.
- Expected expiration: May 5th in 2026
- Creation date: May 5th in 2016
- Renew date: May 5th in 2016